Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3β and attenuated by lithium

Brain Research

Volumn 919, Issue 1, 2001, Pages 106-114

  King, Taj D ^a   Bijur, Gautam N ^a   Jope, Richard S ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Glycogen synthase kinase; Lithium; MPP; Parkinson's disease; Rotenone

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM; MITOCHONDRIAL ENZYME; PHOSPHATIDYLINOSITOL 3 KINASE; ROTENONE; SOMATOMEDIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

1-METHYL-4-PHENYLPYRIDINIUM; 1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CASPASE 3; CASPASES; CHROMONES; DRUG SYNERGISM; ELECTRON TRANSPORT COMPLEX I; ENZYME ACTIVATION; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASES; HERBICIDES; HUMANS; LITHIUM; MITOCHONDRIA; MORPHOLINES; NADH, NADPH OXIDOREDUCTASES; ROTENONE; TUMOR CELLS, CULTURED;

EID: 0035900197     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)03005-0     Document Type: Article

References (58)

1. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): Structural and functional homology with the Drosophila DSTPK61 kinase
2. Chronic systemic pesticide exposure reproduces features of Parkinson's disease
3. Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium
4. Involvement of tubulin in MPP+ neurotoxicity on NGF-differentiated PC12 cells
5. Regulation of cell death protease caspase-9 by phosphorylation
6. Caspases: The executioners of apoptosis
7. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
8. Cellular survival: A play in three Akts
9. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
10. Chronic Parkinsonism secondary to intravenous injection of meperidine analogues
11. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
12. Regulation of neuronal survival by the serine-threonine protein kinase Akt
13. MPP+ induced SH-SY5Y apoptosis is potentiated by cyclosporin A and inhibited by aristolochic acid
14. Characterization and time course of MPP+ -induced apoptosis in human SH-SY5Y neuroblastoma cells
15. Low concentrations of 1-methyl-4-phenylpyridinium ion induce caspase-mediated apoptosis in human SH-SY5Y neuroblastoma cells
16. Mitochondria and apoptosis
17. Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: Relevance to Parkinson's disease
18. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
19. The role of caspases in apoptosis
20. Role of glycogen synthase kinase-3β in neuronal apoptosis induced by trophic withdrawal
21. 1-Methyl-4-phenyl-pyridinium ion (MPP+) causes DNA fragmentation and increases the Bcl-2 expression in human neuroblastoma, SH-SY5Y cells, through different mechanisms
22. Cell death mechanisms in Parkinson's disease
23. Anti-bipolar therapy: Mechanism of action of lithium
24. NGF, BDNF and NT-5, but not NT-3 protect against MPP+ toxicity and oxidative stress in neonatal animals
25. Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells
26. A molecular mechanism for the effect of lithium on development
27. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt
28. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis
29. MPTP: Current concepts and controversies
30. Glycogen synthase kinase-3β, mood stabilizers, and neuroprotection
31. Insulin-like growth factor I rescues SH-SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death
32. Apoptosis in neurodegenerative disorders
33. Neurodegenerative disorders and ischemic brain diseases
34. MPTP, MPP+ and mitochondrial function
35. Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats
36. Etiology and pathogenesis of Parkinson's disease
37. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway
38. Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism
39. Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal
40. Akt1/PKBα protects PC12 cells against the Parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium and reduces the levels of oxygen-free radicals
41. MPP+ induced apoptotic cell death in SH-SY5Y neuroblastoma cells: An electron microscope study
42. Phosphoinositide 3-kinase: The key switch mechanism in insulin signalling
43. Nerve growth factor prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced cell death via the Akt pathway by suppressing caspase-3-like activity using PC12 cells: Relevance to therapeutical application for parkinson's disease
44. Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner
45. Cytotoxic effects of MPTP on SH-SY5Y human neuroblastoma cells
46. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: Involvement of the glutathione system
47. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
48. Astrocyte responses to dopaminergic denervations by 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as evidenced by glial fibrillary acidic protein immunohistochemistry
49. Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity
50. Growth factors prevent changes in Bcl-2 and Bax expression and neuronal apoptosis induced by nitric oxide
51. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease
52. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase
53. Caspases: Enemies within
54. The PI3K-PDK1 connection: More than just a road to PKB
55. Mitochondrial respiratory chain inhibitors induce apoptosis
56. Apoptosis induction by a dopaminergic neurotoxin, 1-methyl-4-phenylpyridinium ion (MPP+), and inhibition by epidermal growth factor in GH3 cells
57. Insulin-like growth factor-1-induced phosphorylation of the forkhead family transcription factor FKHRL1 is mediated by Akt kinase in PC12 cells
58. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9